Labcorp Holdings annual total liabilities
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Total Liabilities Growth & History (LH)
Labcorp Holdings's total liabilities was $9.76B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.76B | −$556.5M | −5.40% |
| 2024 | 2024-12-31 | $10.31B | $1.48B | +16.73% |
| 2023 | 2023-12-31 | $8.83B | −$1.21B | −12.00% |
| 2022 | 2022-12-31 | $10.04B | −$51.8M | −0.51% |
| 2021 | 2021-12-31 | $10.09B | −$523.0M | −4.93% |
| 2020 | 2020-12-31 | $10.61B | $155.1M | +1.48% |
| 2019 | 2019-12-31 | $10.46B | $1.26B | +13.75% |
| 2018 | 2018-12-31 | $9.19B | −$653.3M | −6.63% |
| 2017 | 2017-12-31 | $9.85B | $1.12B | +12.86% |
| 2016 | 2016-12-31 | $8.73B | −$418.7M | −4.58% |
| 2015 | 2015-12-31 | $9.14B | $4.68B | +104.87% |
| 2014 | 2014-12-31 | $4.46B | $8.4M | +0.19% |
| 2013 | 2013-12-31 | $4.46B | $398.3M | +9.82% |
| 2012 | 2012-12-31 | $4.06B | $468.8M | +13.07% |
| 2011 | 2011-12-31 | $3.59B | −$112.8M | −3.05% |
| 2010 | 2010-12-31 | $3.70B | $969.2M | +35.48% |
| 2009 | 2009-12-31 | $2.73B | −$128.2M | −4.48% |
| 2008 | 2008-12-31 | $2.86B | — | — |
Labcorp Holdings quarterly total liabilities
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.91B | $338.6M | +3.54% |
| Q1 2026 | 2026-03-31 | $10.34B | $1.06B | +11.41% |
| Q4 2025 | 2025-12-31 | $9.76B | −$556.5M | −5.40% |
| Q3 2025 | 2025-09-30 | $9.55B | −$878.5M | −8.43% |
| Q2 2025 | 2025-06-30 | $9.57B | $879.0M | +10.11% |
| Q1 2025 | 2025-03-31 | $9.28B | $725.9M | +8.48% |
| Q4 2024 | 2024-12-31 | $10.31B | $1.48B | +16.73% |
| Q3 2024 | 2024-09-30 | $10.43B | $1.43B | +15.94% |
| Q2 2024 | 2024-06-30 | $8.69B | −$222.4M | −2.49% |
| Q1 2024 | 2024-03-31 | $8.56B | −$1.28B | −13.04% |
| Q4 2023 | 2023-12-31 | $8.83B | −$1.21B | −12.00% |
| Q3 2023 | 2023-09-30 | $8.99B | −$721.4M | −7.43% |
| Q2 2023 | 2023-06-30 | $8.91B | −$1.07B | −10.70% |
| Q1 2023 | 2023-03-31 | $9.84B | −$147.5M | −1.48% |
| Q4 2022 | 2022-12-31 | $10.04B | −$51.8M | −0.51% |
| Q3 2022 | 2022-09-30 | $9.71B | −$606.5M | −5.88% |
| Q2 2022 | 2022-06-30 | $9.98B | −$168.6M | −1.66% |
| Q1 2022 | 2022-03-31 | $9.99B | −$388.0M | −3.74% |
| Q4 2021 | 2021-12-31 | $10.09B | −$523.0M | −4.93% |
| Q3 2021 | 2021-09-30 | $10.32B | −$159.2M | −1.52% |
| Q2 2021 | 2021-06-30 | $10.15B | −$325.9M | −3.11% |
| Q1 2021 | 2021-03-31 | $10.37B | $114.9M | +1.12% |
| Q4 2020 | 2020-12-31 | $10.61B | $155.1M | +1.48% |
| Q3 2020 | 2020-09-30 | $10.48B | −$116.4M | −1.10% |
| Q2 2020 | 2020-06-30 | $10.48B | −$103.1M | −0.97% |
| Q1 2020 | 2020-03-31 | $10.26B | $419.8M | +4.27% |
| Q4 2019 | 2019-12-31 | $10.46B | $1.26B | +13.75% |
| Q3 2019 | 2019-09-30 | $10.60B | $1.20B | +12.82% |
| Q2 2019 | 2019-06-30 | $10.58B | $1.13B | +12.00% |
| Q1 2019 | 2019-03-31 | $9.84B | $12.5M | +0.13% |
| Q4 2018 | 2018-12-31 | $9.19B | −$653.3M | −6.63% |
| Q3 2018 | 2018-09-30 | $9.39B | −$1.15B | −10.87% |
| Q2 2018 | 2018-06-30 | $9.45B | $438.3M | +4.87% |
| Q1 2018 | 2018-03-31 | $9.83B | $1.07B | +12.16% |
| Q4 2017 | 2017-12-31 | $9.85B | $1.12B | +12.86% |
| Q3 2017 | 2017-09-30 | $10.54B | $1.59B | +17.83% |
| Q2 2017 | 2017-06-30 | $9.01B | $138.4M | +1.56% |
| Q1 2017 | 2017-03-31 | $8.76B | −$466.3M | −5.05% |
| Q4 2016 | 2016-12-31 | $8.73B | −$418.7M | −4.58% |
| Q3 2016 | 2016-09-30 | $8.94B | −$549.3M | −5.79% |
| Q2 2016 | 2016-06-30 | $8.87B | −$808.9M | −8.36% |
| Q1 2016 | 2016-03-31 | $9.23B | −$388.7M | −4.04% |
| Q4 2015 | 2015-12-31 | $9.14B | $4.68B | +104.87% |
| Q3 2015 | 2015-09-30 | $9.49B | $5.05B | +113.69% |
| Q2 2015 | 2015-06-30 | $9.68B | $5.21B | +116.58% |
| Q1 2015 | 2015-03-31 | $9.62B | $5.14B | +115.02% |
| Q4 2014 | 2014-12-31 | $4.46B | $8.4M | +0.19% |
| Q3 2014 | 2014-09-30 | $4.44B | $341.5M | +8.33% |
| Q2 2014 | 2014-06-30 | $4.47B | $561.0M | +14.35% |
| Q1 2014 | 2014-03-31 | $4.47B | $702.3M | +18.63% |
| Q4 2013 | 2013-12-31 | $4.46B | $398.3M | +9.82% |
| Q3 2013 | 2013-09-30 | $4.10B | $24.4M | +0.60% |
| Q2 2013 | 2013-06-30 | $3.91B | $461.8M | +13.40% |
| Q1 2013 | 2013-03-31 | $3.77B | $257.8M | +7.34% |
| Q4 2012 | 2012-12-31 | $4.06B | $468.8M | +13.07% |
| Q3 2012 | 2012-09-30 | $4.08B | $586.4M | +16.80% |
| Q2 2012 | 2012-06-30 | $3.45B | −$120.8M | −3.39% |
| Q1 2012 | 2012-03-31 | $3.51B | −$267.6M | −7.08% |
| Q4 2011 | 2011-12-31 | $3.59B | −$112.8M | −3.05% |
| Q3 2011 | 2011-09-30 | $3.49B | $732.9M | +26.58% |
| Q2 2011 | 2011-06-30 | $3.57B | $837.0M | +30.66% |
| Q1 2011 | 2011-03-31 | $3.78B | $1.02B | +37.18% |
| Q4 2010 | 2010-12-31 | $3.70B | $969.2M | +35.48% |
| Q3 2010 | 2010-09-30 | $2.76B | $96.5M | +3.63% |
| Q2 2010 | 2010-06-30 | $2.73B | $155.3M | +6.03% |
| Q1 2010 | 2010-03-31 | $2.76B | — | — |
| Q4 2009 | 2009-12-31 | $2.73B | −$128.2M | −4.48% |
| Q3 2009 | 2009-09-30 | $2.66B | — | — |
| Q2 2009 | 2009-06-30 | $2.57B | — | — |
| Q4 2008 | 2008-12-31 | $2.86B | — | — |
Labcorp Holdings total liabilities trends
Over the last five fiscal years, Labcorp Holdings's total liabilities decreased from $10.61B to $9.76B, a change of −$858.4M. The latest reported quarter, Q2 2026, shows $9.91B.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...